These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28777871)

  • 1. A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation.
    Zhang H; Lian M; Zhang J; Bian Z; Tang R; Miao Q; Peng Y; Fang J; You Z; Invernizzi P; Wang Q; Gershwin ME; Ma X
    Hepatology; 2018 Jan; 67(1):232-246. PubMed ID: 28777871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure.
    Zeng Y; Li Y; Xu Z; Gan W; Lu L; Huang X; Lin C
    J Med Virol; 2019 Aug; 91(8):1510-1518. PubMed ID: 30905084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota-Derived Butyrate Induces Epigenetic and Metabolic Reprogramming in Myeloid-Derived Suppressor Cells to Alleviate Primary Biliary Cholangitis.
    Wang R; Li B; Huang B; Li Y; Liu Q; Lyu Z; Chen R; Qian Q; Liang X; Pu X; Wu Y; Chen Y; Miao Q; Wang Q; Lian M; Xiao X; Leung PSC; Gershwin ME; You Z; Ma X; Tang R
    Gastroenterology; 2024 Sep; 167(4):733-749.e3. PubMed ID: 38810839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients.
    Papadaki MA; Aggouraki D; Vetsika EK; Xenidis N; Kallergi G; Kotsakis A; Georgoulias V
    Anticancer Res; 2021 Feb; 41(2):661-670. PubMed ID: 33517270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
    Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
    J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
    Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
    J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell-Suppressor Mechanisms.
    Cao LY; Chung JS; Teshima T; Feigenbaum L; Cruz PD; Jacobe HT; Chong BF; Ariizumi K
    J Invest Dermatol; 2016 Sep; 136(9):1801-1810. PubMed ID: 27236103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
    Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
    Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-35 Regulates Immune Microenvironment of Autoimmune Hepatitis Through Inducing the Expansion of Myeloid-Derived Suppressor Cells.
    Lian M; Zhang J; Zhao L; Chen X; Peng Y; Wang Q; Chen S; Ma X
    Front Immunol; 2019; 10():2577. PubMed ID: 31787974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
    Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
    J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Immunobiology of Receptor Activator for Nuclear Factor Kappa B Ligand and Myeloid-Derived Suppressor Cell Activation in Immunoglobulin G4-Related Sclerosing Cholangitis.
    Lian M; Wang Q; Jiang X; Zhang J; Wei Y; Li Y; Li B; Chen W; Zhang H; Miao Q; Peng Y; Xiao X; Sheng L; Zhang W; Fang J; Tang R; Gershwin ME; Ma X
    Hepatology; 2018 Nov; 68(5):1922-1936. PubMed ID: 29774578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
    Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
    Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
    Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
    Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Relationship between Hepatic Myeloid-Derived Suppressor Cells and Clinicopathological Parameters in Patients with Chronic Liver Disease.
    Zhou Z; Lai P; Zhang S; Wang Y; Qu N; Lu D; Gao L; Xu L; Yang Y; Zhang T; Sun X; Zheng X; Liu Y; Liang H; Chen S
    Biomed Res Int; 2021; 2021():6612477. PubMed ID: 33860040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical and prognostic significance of CD14(+)HLA-DR(-/low) myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy.
    Wang D; An G; Xie S; Yao Y; Feng G
    Tumour Biol; 2016 Aug; 37(8):10427-33. PubMed ID: 26846107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.
    Jordan KR; Kapoor P; Spongberg E; Tobin RP; Gao D; Borges VF; McCarter MD
    Cancer Immunol Immunother; 2017 Apr; 66(4):503-513. PubMed ID: 28108766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated NKT cells facilitated functional switch of myeloid-derived suppressor cells at inflammation sites in fulminant hepatitis mice.
    Wu D; Shi Y; Wang C; Chen H; Liu Q; Liu J; Zhang L; Wu Y; Xia D
    Immunobiology; 2017 Feb; 222(2):440-449. PubMed ID: 27523745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-Derived Suppressive Cells Deficient in Liver X Receptor α Protected From Autoimmune Hepatitis.
    Li B; Lian M; Li Y; Qian Q; Zhang J; Liu Q; Tang R; Ma X
    Front Immunol; 2021; 12():732102. PubMed ID: 34512667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD14
    Bernsmeier C; Triantafyllou E; Brenig R; Lebosse FJ; Singanayagam A; Patel VC; Pop OT; Khamri W; Nathwani R; Tidswell R; Weston CJ; Adams DH; Thursz MR; Wendon JA; Antoniades CG
    Gut; 2018 Jun; 67(6):1155-1167. PubMed ID: 28592438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells.
    Singh L; Muise ES; Bhattacharya A; Grein J; Javaid S; Stivers P; Zhang J; Qu Y; Joyce-Shaikh B; Loboda A; Zhang C; Meehl M; Chiang DY; Ranganath SH; Rosenzweig M; Brandish PE
    Mol Cancer Res; 2021 Apr; 19(4):702-716. PubMed ID: 33372059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.